pI: 9.7183 |
Length (AA): 479 |
MW (Da): 52851 |
Paralog Number:
1
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
62 | 409 | 3hmj (A) | 674 | 1010 | 18.00 | 0 | 1 | 0.745714 | 0.58 |
63 | 135 | 2cfc (A) | 2 | 74 | 23.00 | 0 | 0.45 | 0.399601 | -0.25 |
64 | 303 | 2cfc (A) | 3 | 236 | 23.00 | 0 | 1 | 0.830844 | -0.89 |
96 | 139 | 4mt5 (A) | 17 | 60 | 39.00 | 0.73 | 0.13 | 0.341058 | 1.44 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 merozoite, ME49 Oocyst. | Hehl AB Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_131445)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G03330 | Rossmann-fold NAD(P)-binding domain-containing protein |
Cryptosporidium hominis | Chro.10039 | dehydrogenase/reductase (SDR family) member 7; CGI-86 protein; retinal short-chain dehydrogenase/reductase 4; 2310016E22Rik |
Cryptosporidium parvum | cgd1_280 | short chain dehydrogenase/reductase of the rossmann fold, signal peptide |
Dictyostelium discoideum | DDB_G0274201 | short-chain dehydrogenase/reductase family protein |
Drosophila melanogaster | Dmel_CG31937 | CG31937 gene product from transcript CG31937-RA |
Homo sapiens | ENSG00000100612 | dehydrogenase/reductase (SDR family) member 7 |
Mus musculus | 209183 | predicted gene 4756 |
Mus musculus | ENSMUSG00000021094 | dehydrogenase/reductase (SDR family) member 7 |
Neospora caninum | NCLIV_037010 | oxidoreductase, short chain dehydrogenase/reductase domain-containing protein, putative |
Neospora caninum | NCLIV_056400 | short-chain dehydrogenase/reductase family protein, putative |
Oryza sativa | 4350245 | Os11g0265400 |
Toxoplasma gondii | TGME49_313050 | oxidoreductase, short chain dehydrogenase/reductase family protein |
Toxoplasma gondii | TGME49_269400 | oxidoreductase, short chain dehydrogenase/reductase family protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_269400 this record | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_313050 | Toxoplasma gondii | Probably non-essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.1
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Macaca mulatta | Hydroxysteroid 11-beta dehydrogenase 1 | 140 aa | 26.5% | 147 aa | Compounds | References |
Plasmodium falciparum | 3-oxoacyl-[acyl-carrier-protein] reductase | 301 aa | 27.0% | 263 aa | Compounds | References |